Trials / Completed
CompletedNCT00971282
Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins
Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center study, randomized, Investigator/Evaluator-blinded bilateral (split-face) comparison. The objective: To assess the benefit of the concomitant use of a Moisturizing Lotion in reducing the skin irritation induced by a adapalen gel treatment in Chinese Subjects.
Detailed description
The interest \& relevance of the concomitant use of a non-comedogenic moisturizer in order to decrease retinoid irritation has already been demonstrated in Caucasian patients. Such interest of associating a moisturizer when Differin® gel is prescribed has not been demonstrated in Asian populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adapalen 0.1% | Intra-individual (split-face) comparison: Differin® 0.1% (whole face) will be applied once daily for 4 weeks. Visits will be conducted weekly for a maximum of 5 visits. |
| OTHER | Cetaphil® | Intra-individual (split-face) comparison: Cetaphil® (only one side of the face) will be applied once daily for 4 weeks. Visits will be conducted weekly for a maximum of 5 visits. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2009-09-03
- Last updated
- 2021-02-18
- Results posted
- 2012-05-15
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT00971282. Inclusion in this directory is not an endorsement.